aspartic acid has been researched along with Demyelinating Diseases in 42 studies
Aspartic Acid: One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter.
aspartic acid : An alpha-amino acid that consists of succinic acid bearing a single alpha-amino substituent
L-aspartic acid : The L-enantiomer of aspartic acid.
Demyelinating Diseases: Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Citrulline was more frequently identified in the brains of patients with early-onset MS than in healthy subjects by (1)H-MR spectroscopy, suggesting an association of increased citrullination of myelin proteins with demyelinating diseases." | 5.14 | Assessment of citrullinated myelin by 1H-MR spectroscopy in early-onset multiple sclerosis. ( Aksu, AO; Anlar, B; Haspolat, S; Karabulut, E; Kurne, A; Kurul, S; Oguz, KK; Senbil, N; Serdaroglu, A; Teber, S, 2009) |
| "The inherited leukodystrophy Canavan disease arises due to a loss of the ability to catabolize N-acetylaspartic acid (NAA) in the brain and constitutes a major point of focus for efforts to define NAA function." | 3.78 | Aspartoacylase supports oxidative energy metabolism during myelination. ( Francis, JS; Leone, P; Markov, V; Strande, L, 2012) |
| " Strongly elevated concentrations of myo-inositol in conjunction with normal or increased choline-containing compounds in all regions investigated point to astrocytosis and demyelination." | 3.72 | Cerebral proton magnetic resonance spectroscopy in infantile Alexander disease. ( Brockmann, K; Dechent, P; Frahm, J; Hanefeld, F; Haupt, M; Meins, M; Sperner, J; Stephani, U, 2003) |
| "Eight patients with advanced breast cancer were entered into a prospective, longitudinal trial that included examination by MR imaging and proton MR spectroscopy before chemotherapy and through 12 months after treatment with carmustine, cyclophosphamide, and cisplatin, combined with autologous hematopoietic progenitor cell support (AHPCS)." | 3.70 | White matter disease induced by high-dose chemotherapy: longitudinal study with MR imaging and proton spectroscopy. ( Brown, MS; Cagnoni, PJ; Jones, RB; Sheeder, JL; Simon, JH; Stears, JC; Stemmer, SM, 1998) |
| "Epilepsy is too complex to be considered as a disease; it is more of a syndrome, characterized by seizures, which can be caused by a diverse array of afflictions." | 2.55 | Control of seizures by ketogenic diet-induced modulation of metabolic pathways. ( Akabani, G; Aramayo, R; Clanton, RM; Wu, G, 2017) |
| "Our results suggest that demyelination plays an important role in WM disruption post-injury in a subgroup of msTBI children and indicate the utility of multi-modal imaging." | 1.48 | Magnetic resonance spectroscopy of fiber tracts in children with traumatic brain injury: A combined MRS - Diffusion MRI study. ( Alger, J; Asarnow, RF; Babbitt, C; Babikian, T; Dennis, EL; Giza, CC; Jin, Y; Johnson, J; Mink, R; Olsen, A; Rashid, F; Thompson, PM; Villalon-Reina, JE, 2018) |
| "Ovarian teratoma was detected and resected in only one case of initial episode." | 1.42 | [Clinical analysis of relapsing anti-N-methyl-D-aspartate receptor encephalitis]. ( Bin, P; Dawei, S; Haitao, R; Hang, S; Hongzhi, G; Liying, C; Qiang, L; Qing, L; Weize, K; Yan, H; Yicheng, Z; Yuan, J, 2015) |
| "Tumefactive demyelination (TD) is a relatively uncommon entity which mimics other focal intracranial lesions." | 1.37 | Conventional and advanced magnetic resonance imaging in tumefactive demyelination. ( Chatterjee, S; Kesavadas, C; Saini, J; Thomas, B, 2011) |
| "Active demyelination or increased myelin turnover might contribute to the hitherto unexplained WMD of this rare disorder." | 1.33 | White-matter disease in 18q deletion (18q-) syndrome: magnetic resonance spectroscopy indicates demyelination or increased myelin turnover rather than dysmyelination. ( Anhuf, D; Häusler, M; Möller-Hartmann, W; Ramaekers, VT; Schüler, H; Thron, A; Zerres, K, 2005) |
| "A Cho elevation may precede visible demyelination on T2-weighted images." | 1.30 | The value of new MRI techniques in adrenoleukodystrophy. ( Engelbrecht, V; Gärtner, J; Kahn, T; Mödder, U; Rassek, M, 1997) |
| "MR studies of these infants showed obstructive hydrocephalus caused by mass effect produced by an enlarged cerebellum." | 1.30 | Imaging studies in a unique familial dysmyelinating disorder. ( Duhaime, AC; Gripp, KW; Molloy, PT; Muenke, M; Rorke, LB; Schut, L; Tucker, SH; Wang, ZJ; Zackai, EH; Zimmerman, RA, 1998) |
| "The mechanisms behind the demyelination that is characteristic of multiple sclerosis (MS) are still poorly understood." | 1.30 | Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. ( Bitsch, A; Brück, W; Bruhn, H; Frahm, J; Lassmann, H; Stringaris, A; Vougioukas, V, 1999) |
| "The two patients with MELAS syndrome had large decreases of NAA signal (50% and 20% of normal values, respectively) from their occipital lobe lesions during the acute stroke-like episodes." | 1.29 | Reversible decreases in N-acetylaspartate after acute brain injury. ( Arnold, DL; De Stefano, N; Matthews, PM, 1995) |
| "Despite regional variability of demyelination, proton magnetic resonance spectroscopy revealed a specific metabolic pattern in all patients, with only moderate reduction of N-acetylaspartate, normal or reduced choline-containing compounds, normal or enhanced myo-inositol and no detectable lactate, which differs from findings in progressive cerebral adrenoleukodystrophy which usually exhibits a severe reduction of N-acetylaspartate and marked increases of choline-containing compounds, myo-inositol, and lactate." | 1.29 | Arrested cerebral adrenoleukodystrophy: a clinical and proton magnetic resonance spectroscopy study in three patients. ( Frahm, J; Hanefeld, F; Hunneman, DH; Jost, W; Korenke, GC; Krasemann, E; Pouwels, PJ; Stoeckler, S, 1996) |
| "Four grades of demyelination and three grades of cerebral atrophy were distinguished by magnetic resonance imaging criteria." | 1.28 | 1H and 31P magnetic resonance spectroscopy of the brain in degenerative cerebral disorders. ( den Hollander, JA; Luyten, PR; Nauta, JJ; Valk, J; van der Grond, J; van der Knaap, MS, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (4.76) | 18.7374 |
| 1990's | 16 (38.10) | 18.2507 |
| 2000's | 11 (26.19) | 29.6817 |
| 2010's | 13 (30.95) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dennis, EL | 1 |
| Babikian, T | 1 |
| Alger, J | 1 |
| Rashid, F | 1 |
| Villalon-Reina, JE | 1 |
| Jin, Y | 1 |
| Olsen, A | 1 |
| Mink, R | 1 |
| Babbitt, C | 1 |
| Johnson, J | 1 |
| Giza, CC | 1 |
| Thompson, PM | 1 |
| Asarnow, RF | 1 |
| Lu, SS | 1 |
| Kim, SJ | 1 |
| Kim, HS | 2 |
| Choi, CG | 1 |
| Lim, YM | 1 |
| Kim, EJ | 1 |
| Kim, DY | 1 |
| Cho, SH | 1 |
| Nave, KA | 1 |
| Werner, HB | 1 |
| Praet, J | 1 |
| Orije, J | 1 |
| Kara, F | 1 |
| Guglielmetti, C | 1 |
| Santermans, E | 1 |
| Daans, J | 1 |
| Hens, N | 1 |
| Verhoye, M | 1 |
| Berneman, Z | 1 |
| Ponsaerts, P | 1 |
| Van der Linden, A | 1 |
| Takanashi, J | 1 |
| Wootla, B | 1 |
| Denic, A | 2 |
| Watzlawik, JO | 1 |
| Warrington, AE | 1 |
| Rodriguez, M | 2 |
| Hongzhi, G | 1 |
| Weize, K | 1 |
| Bin, P | 1 |
| Yan, H | 1 |
| Qiang, L | 1 |
| Yuan, J | 1 |
| Qing, L | 1 |
| Hang, S | 1 |
| Haitao, R | 1 |
| Yicheng, Z | 1 |
| Dawei, S | 1 |
| Liying, C | 1 |
| Clanton, RM | 1 |
| Wu, G | 1 |
| Akabani, G | 1 |
| Aramayo, R | 1 |
| Oguz, KK | 1 |
| Kurne, A | 1 |
| Aksu, AO | 1 |
| Karabulut, E | 1 |
| Serdaroglu, A | 1 |
| Teber, S | 1 |
| Haspolat, S | 1 |
| Senbil, N | 1 |
| Kurul, S | 1 |
| Anlar, B | 1 |
| Machado, A | 1 |
| Soares-Fernandes, J | 1 |
| Ribeiro, M | 1 |
| Rodrigues, M | 1 |
| Cerqueira, J | 1 |
| Ferreira, C | 1 |
| Bieber, A | 1 |
| Warrington, A | 1 |
| Mishra, PK | 1 |
| Macura, S | 1 |
| Sohn, SY | 1 |
| Ko, YJ | 1 |
| Hong, JM | 1 |
| Kim, SH | 1 |
| Kim, JH | 1 |
| Chi, JG | 1 |
| Moon, SY | 1 |
| Saini, J | 1 |
| Chatterjee, S | 1 |
| Thomas, B | 1 |
| Kesavadas, C | 1 |
| Francis, JS | 1 |
| Strande, L | 1 |
| Markov, V | 1 |
| Leone, P | 1 |
| Khalil, M | 1 |
| Enzinger, C | 1 |
| Langkammer, C | 1 |
| Ropele, S | 1 |
| Mader, A | 1 |
| Trentini, A | 1 |
| Vane, ML | 1 |
| Wallner-Blazek, M | 1 |
| Bachmaier, G | 1 |
| Archelos, JJ | 1 |
| Koel-Simmelink, MJ | 1 |
| Blankenstein, MA | 1 |
| Fuchs, S | 1 |
| Fazekas, F | 1 |
| Teunissen, CE | 1 |
| Tajima, Y | 1 |
| Mito, Y | 1 |
| Yanai, M | 1 |
| Fukazawa, Y | 1 |
| Saindane, AM | 1 |
| Cha, S | 1 |
| Law, M | 1 |
| Xue, X | 1 |
| Knopp, EA | 1 |
| Zagzag, D | 1 |
| Brockmann, K | 1 |
| Dechent, P | 1 |
| Meins, M | 1 |
| Haupt, M | 1 |
| Sperner, J | 1 |
| Stephani, U | 1 |
| Frahm, J | 3 |
| Hanefeld, F | 2 |
| Häusler, M | 1 |
| Anhuf, D | 1 |
| Schüler, H | 1 |
| Ramaekers, VT | 1 |
| Thron, A | 1 |
| Zerres, K | 1 |
| Möller-Hartmann, W | 1 |
| Porto, L | 1 |
| Hattingen, E | 1 |
| Pilatus, U | 1 |
| Kieslich, M | 1 |
| Yan, B | 1 |
| Schwabe, D | 1 |
| Zanella, FE | 1 |
| Lanfermann, H | 1 |
| Cianfoni, A | 1 |
| Niku, S | 1 |
| Imbesi, SG | 1 |
| Hiehle, JF | 1 |
| Lenkinski, RE | 2 |
| Grossman, RI | 2 |
| Dousset, V | 1 |
| Ramer, KN | 1 |
| Schnall, MD | 1 |
| Cohen, JA | 1 |
| Gonzalez-Scarano, F | 2 |
| Hájek, M | 1 |
| Hejcmanová, L | 1 |
| Prádný, J | 1 |
| De Stefano, N | 2 |
| Matthews, PM | 3 |
| Antel, JP | 2 |
| Preul, M | 1 |
| Francis, G | 1 |
| Arnold, DL | 3 |
| Confort-Gouny, S | 1 |
| Vion-Dury, J | 1 |
| Chabrol, B | 1 |
| Nicoli, F | 1 |
| Cozzone, PJ | 1 |
| Kimura, H | 1 |
| Korenke, GC | 1 |
| Pouwels, PJ | 2 |
| Hunneman, DH | 1 |
| Stoeckler, S | 1 |
| Krasemann, E | 1 |
| Jost, W | 1 |
| Engelbrecht, V | 1 |
| Rassek, M | 1 |
| Gärtner, J | 1 |
| Kahn, T | 1 |
| Mödder, U | 1 |
| Brown, MS | 1 |
| Stemmer, SM | 1 |
| Simon, JH | 1 |
| Stears, JC | 1 |
| Jones, RB | 1 |
| Cagnoni, PJ | 1 |
| Sheeder, JL | 1 |
| Gripp, KW | 1 |
| Zimmerman, RA | 2 |
| Wang, ZJ | 1 |
| Rorke, LB | 1 |
| Duhaime, AC | 1 |
| Schut, L | 1 |
| Molloy, PT | 1 |
| Tucker, SH | 1 |
| Zackai, EH | 1 |
| Muenke, M | 1 |
| Bitsch, A | 1 |
| Bruhn, H | 1 |
| Vougioukas, V | 1 |
| Stringaris, A | 1 |
| Lassmann, H | 1 |
| Brück, W | 1 |
| Davie, CA | 1 |
| Silver, NC | 1 |
| Barker, GJ | 1 |
| Tofts, PS | 1 |
| Thompson, AJ | 1 |
| McDonald, WI | 1 |
| Miller, DH | 1 |
| van der Knaap, MS | 2 |
| Wevers, RA | 1 |
| Struys, EA | 1 |
| Verhoeven, NM | 1 |
| Engelke, UF | 1 |
| Feikema, W | 1 |
| Valk, J | 2 |
| Jakobs, C | 1 |
| Blüml, S | 1 |
| Hwang, JH | 1 |
| Moreno, A | 1 |
| Ross, BD | 1 |
| Pozdniakov, AV | 1 |
| Tiutin, LA | 1 |
| Bisaga, GN | 1 |
| Odinak, MM | 1 |
| Espay, AJ | 1 |
| Bodensteiner, JB | 1 |
| Patel, H | 1 |
| van der Grond, J | 1 |
| Luyten, PR | 1 |
| den Hollander, JA | 1 |
| Nauta, JJ | 1 |
| Francis, GS | 1 |
| O'Connor, J | 1 |
| Marks, HG | 1 |
| Caro, PA | 1 |
| Wang, ZY | 1 |
| Detre, JA | 1 |
| Bogdan, AR | 1 |
| Gusnard, DA | 1 |
| Elpeleg, ON | 1 |
| Amir, N | 1 |
| Glick, B | 1 |
| Gross-Tzur, V | 1 |
| Zelnik, N | 1 |
| Tamiri, Z | 1 |
| Gay, C | 1 |
| Divry, P | 1 |
| Macabeo, V | 1 |
| Dumont, C | 1 |
| Gilly, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Clinical Features of Combined Central and Peripheral Demyelination[NCT04664647] | 30 participants (Anticipated) | Observational | 2020-12-31 | Not yet recruiting | |||
| Mapping the Natural History of Traumatic Spinal Cord Injury in the Sensorimotor Cortex Using Functional Magnetic Resonance Imaging, Magnetic Resonance Spectroscopy and Diffusion Tensor Imaging[NCT00790361] | 20 participants (Actual) | Observational | 2009-06-18 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for aspartic acid and Demyelinating Diseases
| Article | Year |
|---|---|
Myelination of the nervous system: mechanisms and functions.
Topics: Adenosine Triphosphate; Animals; Aspartic Acid; Axons; Central Nervous System; Charcot-Marie-Tooth D | 2014 |
Neurochemistry of Hypomyelination Investigated with MR Spectroscopy.
Topics: Animals; Aspartic Acid; Brain Chemistry; Choline; Creatine; Demyelinating Diseases; Disease Models, | 2015 |
Antibody-Mediated Oligodendrocyte Remyelination Promotes Axon Health in Progressive Demyelinating Disease.
Topics: Animals; Antibodies; Aspartic Acid; Axons; Brain Stem; Cardiovirus Infections; Demyelinating Disease | 2016 |
Control of seizures by ketogenic diet-induced modulation of metabolic pathways.
Topics: Amino Acids, Essential; Aspartic Acid; Demyelinating Diseases; Diet, Ketogenic; Epilepsy; Fatty Acid | 2017 |
1 trial available for aspartic acid and Demyelinating Diseases
| Article | Year |
|---|---|
Assessment of citrullinated myelin by 1H-MR spectroscopy in early-onset multiple sclerosis.
Topics: Adolescent; Age of Onset; Aspartic Acid; Child; Child, Preschool; Choline; Citrulline; Creatine; Dem | 2009 |
37 other studies available for aspartic acid and Demyelinating Diseases
| Article | Year |
|---|---|
Magnetic resonance spectroscopy of fiber tracts in children with traumatic brain injury: A combined MRS - Diffusion MRI study.
Topics: Adolescent; Anisotropy; Aspartic Acid; Brain Damage, Chronic; Brain Injuries, Traumatic; Child; Chol | 2018 |
Utility of proton MR spectroscopy for differentiating typical and atypical primary central nervous system lymphomas from tumefactive demyelinating lesions.
Topics: Aspartic Acid; Biomarkers; Brain Neoplasms; Choline; Demyelinating Diseases; Diagnosis, Differential | 2014 |
Cuprizone-induced demyelination and demyelination-associated inflammation result in different proton magnetic resonance metabolite spectra.
Topics: Animals; Aspartic Acid; Brain Chemistry; Choline; Creatine; Cuprizone; Demyelinating Diseases; Dipep | 2015 |
[Clinical analysis of relapsing anti-N-methyl-D-aspartate receptor encephalitis].
Topics: Adolescent; Adult; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Aspartic Acid; Autoantibodies; B | 2015 |
Alcohol abuse and acute behavioural disturbances in a 24-year-old patient. Diagnosis: Marchiafava-Bignami disease (MBD).
Topics: Alcohol-Induced Disorders, Nervous System; Alcoholism; Aspartic Acid; Choline; Corpus Callosum; Crea | 2009 |
Brainstem 1H nuclear magnetic resonance (NMR) spectroscopy: marker of demyelination and repair in spinal cord.
Topics: Animals; Aspartic Acid; Biomarkers; Brain Stem; Demyelinating Diseases; Friend murine leukemia virus | 2009 |
A case of pigmentary orthochromatic leukodystrophy with findings of proton MR spectroscopy and serial brain MRIs.
Topics: Adult; Antigens, CD; Aspartic Acid; Brain; Brain Diseases; Brain Mapping; Creatine; Demyelinating Di | 2010 |
Conventional and advanced magnetic resonance imaging in tumefactive demyelination.
Topics: Adolescent; Adult; Aspartic Acid; Brain; Brain Mapping; Child; Choline; Contrast Media; Demyelinatin | 2011 |
Aspartoacylase supports oxidative energy metabolism during myelination.
Topics: Amidohydrolases; Animals; Aspartic Acid; Biomarkers; Canavan Disease; Cells, Cultured; Chromatograph | 2012 |
CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome.
Topics: Adult; Aspartic Acid; Biomarkers; Brain; Demyelinating Diseases; Female; Humans; Magnetic Resonance | 2013 |
Unusual basal ganglia lesions in a diabetic uraemic patient proven to be demyelination: first pathological observation.
Topics: Aspartic Acid; Basal Ganglia; Basal Ganglia Diseases; Demyelinating Diseases; Diabetic Nephropathies | 2012 |
Proton MR spectroscopy of tumefactive demyelinating lesions.
Topics: Adult; Aspartic Acid; Brain; Brain Neoplasms; Creatine; Demyelinating Diseases; Diagnosis, Different | 2002 |
Cerebral proton magnetic resonance spectroscopy in infantile Alexander disease.
Topics: Alexander Disease; Aspartic Acid; Brain; Child; Child, Preschool; Demyelinating Diseases; Disease Pr | 2003 |
White-matter disease in 18q deletion (18q-) syndrome: magnetic resonance spectroscopy indicates demyelination or increased myelin turnover rather than dysmyelination.
Topics: Aspartic Acid; Brain Diseases; Choline; Chromosome Deletion; Chromosomes, Human, Pair 18; Demyelinat | 2005 |
Proton magnetic resonance spectroscopy in childhood brainstem lesions.
Topics: Adolescent; Amino Acids; Aspartic Acid; Brain Chemistry; Brain Diseases; Brain Stem; Brain Stem Neop | 2007 |
Metabolite findings in tumefactive demyelinating lesions utilizing short echo time proton magnetic resonance spectroscopy.
Topics: Adolescent; Adult; Aspartic Acid; Brain; Brain Neoplasms; Choline; Creatine; Demyelinating Diseases; | 2007 |
Correlation of spectroscopy and magnetization transfer imaging in the evaluation of demyelinating lesions and normal appearing white matter in multiple sclerosis.
Topics: Adolescent; Adult; Aged; Aspartic Acid; Brain; Choline; Cohort Studies; Creatine; Demyelinating Dise | 1994 |
Proton in vivo spectroscopy of patients with hyperphenylalaninaemia.
Topics: Adult; Aspartic Acid; Biopterins; Brain; Brain Chemistry; Brain Diseases; Child; Choline; Creatine; | 1993 |
Chemical pathology of acute demyelinating lesions and its correlation with disability.
Topics: Adult; Aspartic Acid; Brain Chemistry; Choline; Demyelinating Diseases; Disability Evaluation; Femal | 1995 |
Reversible decreases in N-acetylaspartate after acute brain injury.
Topics: Acute Disease; Aspartic Acid; Brain; Demyelinating Diseases; Humans; Magnetic Resonance Spectroscopy | 1995 |
Localised proton magnetic resonance spectroscopy in X-linked adrenoleukodystrophy.
Topics: Adolescent; Adrenoleukodystrophy; Adult; Aspartic Acid; Brain; Child; Creatine; Demyelinating Diseas | 1995 |
Proton MR spectroscopy and magnetization transfer ratio in multiple sclerosis: correlative findings of active versus irreversible plaque disease.
Topics: Adult; Aspartic Acid; Brain; Brain Diseases; Brain Edema; Choline; Chronic Disease; Creatine; Demyel | 1996 |
Arrested cerebral adrenoleukodystrophy: a clinical and proton magnetic resonance spectroscopy study in three patients.
Topics: Aspartic Acid; Brain; Brain Diseases, Metabolic; Child; Choline; Demyelinating Diseases; Female; Hum | 1996 |
The value of new MRI techniques in adrenoleukodystrophy.
Topics: Adolescent; Adrenoleukodystrophy; Aspartic Acid; Brain; Child; Child, Preschool; Choline; Demyelinat | 1997 |
White matter disease induced by high-dose chemotherapy: longitudinal study with MR imaging and proton spectroscopy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Brain; Brain Diseases; B | 1998 |
Imaging studies in a unique familial dysmyelinating disorder.
Topics: Adolescent; Adult; Aspartic Acid; Brain; Canavan Disease; Cerebellar Diseases; Cerebral Cortex; Chol | 1998 |
Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy.
Topics: Adult; Aspartic Acid; Axons; Biopsy, Needle; Blood-Brain Barrier; Brain; Cell Division; Choline; Dem | 1999 |
Does the extent of axonal loss and demyelination from chronic lesions in multiple sclerosis correlate with the clinical subgroup?
Topics: Aspartic Acid; Axons; Cerebral Cortex; Chronic Disease; Demyelinating Diseases; Disease Progression; | 1999 |
Leukoencephalopathy associated with a disturbance in the metabolism of polyols.
Topics: Adolescent; Aspartic Acid; Carbohydrate Metabolism, Inborn Errors; Choline; Creatine; Demyelinating | 1999 |
Novel peak assignments of in vivo (13)C MRS in human brain at 1.5 T.
Topics: Adult; Aspartic Acid; Bicarbonates; Brain; Carbon Isotopes; Child, Preschool; Creatine; Demyelinatin | 2000 |
[Proton magnetic-resonance spectroscopy in remitting and secondary-progressive multiple sclerosis].
Topics: Adolescent; Adult; Aspartic Acid; Brain; Choline; Creatine; Demyelinating Diseases; Female; gamma-Am | 2001 |
Episodic coma in a new leukodystrophy.
Topics: Aspartic Acid; Ataxia; Brain; Child; Choline; Coma; Creatine; Demyelinating Diseases; Epilepsy, Post | 2002 |
1H and 31P magnetic resonance spectroscopy of the brain in degenerative cerebral disorders.
Topics: Adult; Aspartic Acid; Atrophy; Brain; Brain Diseases; Child; Creatine; Demyelinating Diseases; Human | 1992 |
Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques.
Topics: Acute Disease; Adult; Aspartic Acid; Biopsy; Brain Chemistry; Brain Neoplasms; Choline; Creatine; De | 1992 |
Use of computed tomography, magnetic resonance imaging, and localized 1H magnetic resonance spectroscopy in Canavan's disease: a case report.
Topics: Amidohydrolases; Amino Acid Metabolism, Inborn Errors; Aspartic Acid; Brain Diseases, Metabolic; Chi | 1991 |
[Organic aciduria in Canavan disease].
Topics: Acids; Aspartic Acid; Demyelinating Diseases; Female; Humans; Infant; Lipidoses; Male | 1989 |
[N-acetylaspartic aciduria: a new form of demyelinating encephalopathy].
Topics: Acids; Aspartic Acid; Consanguinity; Demyelinating Diseases; Encephalitis; Humans | 1988 |